EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
46 hedge funds and large institutions have $73.3M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
-$6.1M |
2 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$960K |
3 |
AMH
Apollo Management Holdings
New York
|
-$909K |
4 |
FTCM
Fir Tree Capital Management
New York
|
-$428K |
5 |
EAM
Exos Asset Management
New York
|
-$103K |